TSU-Pr1人前列腺癌細胞、
- 公司名稱 上海富雨生物科技有限公司
- 品牌
- 型號
- 產地
- 廠商性質 生產廠家
- 更新時間 2025/4/24 14:41:08
- 訪問次數(shù) 72
聯(lián)系方式：陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時請說明是化工儀器網上看到的信息，謝謝!
TSU-Pr1 人前列腺癌細胞
Catalogue No.: C1418
Product Format: a T25 flask
Culture Properties：貼壁
Complete Growth Medium: 89%1640+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
| Item | Specifications |
| a T25 flask | 2X106 |
| Manual | 1 copy |
anti-tumor immune response. It has been approved by the Food and Drug Administration (FDA) for the treatment of various tumor types, including melanoma, non-small cell lung cancer (NSCLC), head ａnd necksquamous cell carcinoma (HNSCC), and urothelial cancer (5). Clinical trials of ICB are currently being evaluated in NEN derived from different origins, including the gastrointestinal tract (GI), pancreas, and lung (6–9). In the phase II KEYNOTE-158 study, anti-PD-1
采購中心
化工儀器網